Thrombin Receptor Modulators: Medicinal Chemistry, Biological Evaluation, and Clinical Application

作者: Cailin Chen* , Bruce E. Maryanoff* , Patricia Andrade-Gordon

DOI: 10.1007/978-0-387-09637-7_12

关键词: ReceptorMedicinal chemistryThrombinGrowth factorThrombin receptorCytokineSerine proteaseCell growthFunction (biology)Medicine

摘要: The serine protease a-thrombin maintains haemostasis through its coagulant, anticoagulant, and platelet-activator functions. This enzyme also has important cellular effects involving cell proliferation, cytokine growth factor release, tissue remodeling, which are mediated by G-protein coupled receptors known as protease-activated (PARs). Thrombin can activate three of the four PAR family members, PAR1 is primary thrombin-responsive receptor in human cells. plays an role during response to injury associated inflammatory processes. blockade offers a new approach for treating various disorders that depend on thrombin generation, including thrombosis restenosis. Antagonists will interrupt thrombin’s function, but not proteolytic activity, thereby providing alternative means attenuate pathological thrombin. chapter deals with topic PAR1, key medicinal chemistry, pharmacology, clinical aspects antagonists, PAR4. full potential antagonists yet be realized commercially, promise novel therapeutics reflected two antiplatelet advanced trials.

参考文章(145)
Jih-Hwa Guh, Yi-Nan Liu, Ya-Ling Chang, Sheng-Chu Kuo, Fang-Yu Lee, Chieh-Yu Peng, Shiow-Lin Pan, Che-Ming Teng, The indazole derivative YD-3 inhibits thrombin-induced vascular smooth muscle cell proliferation and attenuates intimal thickening after balloon injury Thrombosis and Haemostasis. ,vol. 92, pp. 1232- 1239 ,(2004) , 10.1160/TH04-04-0216
Role of thrombin in angiogenesis and tumor progression. Seminars in Thrombosis and Hemostasis. ,vol. 30, pp. 63- 69 ,(2004) , 10.1055/S-2004-822971
Nigel S Cook, Hans-Günter Zerwes, Carlo Tapparelli, Max Powling, Jagjit Singh, Rainer Metternich, Alex Hagenbach, Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Thrombosis and Haemostasis. ,vol. 70, pp. 531- 539 ,(1993) , 10.1055/S-0038-1649618
R R Vassallo, T Kieber-Emmons, K Cichowski, L.F. Brass, Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. Journal of Biological Chemistry. ,vol. 267, pp. 6081- 6085 ,(1992) , 10.1016/S0021-9258(18)42664-6
R.M. Scarborough, M.A. Naughton, W Teng, D.T. Hung, J Rose, T.K. Vu, V.I. Wheaton, C.W. Turck, S.R. Coughlin, Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. Journal of Biological Chemistry. ,vol. 267, pp. 13146- 13149 ,(1992) , 10.1016/S0021-9258(18)42184-9
L.F. Brass, R R Vassallo, E Belmonte, M Ahuja, K Cichowski, J.A. Hoxie, Structure and function of the human platelet thrombin receptor. Studies using monoclonal antibodies directed against a defined domain within the receptor N terminus. Journal of Biological Chemistry. ,vol. 267, pp. 13795- 13798 ,(1992) , 10.1016/S0021-9258(19)49635-X
Mayumi Nakanishi-Matsui, Yao-Wu Zheng, David J. Sulciner, Ethan J. Weiss, Matthew J. Ludeman, Shaun R. Coughlin, PAR3 is a cofactor for PAR4 activation by thrombin Nature. ,vol. 404, pp. 609- 613 ,(2000) , 10.1038/35007085
Mark L. Kahn, Yao-Wu Zheng, Wei Huang, Violeta Bigornia, Dewan Zeng, Stephen Moff, Robert V. Farese, Carmen Tam, Shaun R. Coughlin, A dual thrombin receptor system for platelet activation Nature. ,vol. 394, pp. 690- 694 ,(1998) , 10.1038/29325
M A Kjelsberg, S Cotecchia, J Ostrowski, M G Caron, R J Lefkowitz, Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. Journal of Biological Chemistry. ,vol. 267, pp. 1430- 1433 ,(1992) , 10.1016/S0021-9258(18)45962-5